QGQingmei Guo

Qingmei Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qingmei Guo has a total of 55 co-authors. Here are the top co-authors by number of shared publications:

  • Cuicui Xu

    School of Pharmacy, Shandong University of Traditional Chinese Medicine , Jinan 250355

    3 shared publications
  • Jiafu Wan

    School of Pharmacy Shandong University of Traditional Chinese Medicine Jinan P. R. China

    3 shared publications
  • Pengliang Shi

    Instrumental Analysis Center, Shandong Academy of Chinese Medicine , Jinan 250014

    3 shared publications
  • Fengqin Zhou

    College of Pharmacy Shandong University of Traditional Chinese Medicine Jinan China

    2 shared publications
  • Qingyu Yan

    School of Pharmacy, Shandong University of Traditional Chinese Medicine , Jinan 250355

    2 shared publications
  • Xiaojie Fu

    Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China

    2 shared publications

Latest Publications

  • Open Access

    Qualitative Analysis of Chemical Composition Changes Before and After Lactobacillus Fermented Ziziphi Spinosae Semen by LC‐MS and Prediction of Fermentation Mechanism

    by Jiafu Wan, Yunda Wang, Xiaoxue Yang, Qingmei Guo

    This study aimed to screen dominant Lactobacillus strains for fermenting Ziziphi Spinosae Semen (ZSS), analyze chemical composition changes before and after fermentation, and speculate on the fermentation mechanism. Liquid fermentation of ZSS was conducted using Lactobacillus plantarum , Lactobacillus paracasei , Lactobacillus acidophilus , and Lactobacillus rhamnosus . HPLC was employed to determine the content of spinosin, 6′′′‐feruloylspinosin, jujuboside A, and jujuboside B. Total phenolic content (TPC), total flavonoid content (TFC), and antioxidant capacity were measured using UV spectrophotometry. Principal component analysis (PCA) was employed to identify the optimal fermentation strain, and UPLC‐Q‐Exactive Orbitrap‐MS technology was used for qualitative analysis of chemical components before and after fermentation. Results indicated L. plantarum as the optimal fermentation strain. UPLC‐Q‐Exactive Orbitrap‐MS analysis revealed 41 chemical components in the unfermented sample, reduced to 30 post‐fermentation. L. plantarum was hypothesized to catalyze enzymatic hydrolysis breaking C─O bonds, N─C bonds, acyl groups, and glucosyl groups, facilitating interconversion among compounds.

  • The flavonoids of Trichosanthis Fructus in improving ALI mice based on AUF-MS-SPR

    by Cuicui Xu, Qingyu Yan, Hao Kong, Hong Qi, Pengliang Shi, Yanan Fu, Jiafu Wan, Qitao Zhao, Qingmei Guo

    Objectives: To investigate the anti-inflammatory mechanism and potential bioactive compounds of the flavonoids of Trichosanthis Fructus (TF) in LPS-induced acute lung injury (ALI) mice. Methods: The active fraction of TF was screened based on nitric oxide (NO) levels in RAW264.7 cells, and its antioxidant capacity was evaluated in BEAS-2B cells. Balb/c mice were intratracheally instilled with LPS (3 mg/kg), and the levels of Interleukin-1β (IL-1β), IL-6, and Tumor necrosis factor alpha (TNF-α) in serum and lung were measured. The targets of TF intervention in ALI were predicted using Western blotting. The compounds that bind specifically to the targets were identified by affinity ultrafiltration mass spectrometry, and then validated the binding specificity using surface plasmon resonance technology. Key findings: The NO level in LPS-induced RAW264.7 was significantly reduced by the ethyl acetate fraction of TF (TF-EA), and the reactive oxygen species level in H2O2-induced BEAS-2B cells was also decreased. Subsequently, TF-EA may significantly improve LPS-induced ALI in mice by EGFR and TLR4-mediated PI3K/Akt signaling pathway. The flavonoids especially rutin, luteolin-7-O-glucoside, apigenin-7-O-glucoside, and diosmetin-7-O-glucoside had better binding with Epidermal growth factor receptor (EGFR) and Toll-like receptor 4 (TLR4). Conclusions: The TF-EA may reduce the release of inflammatory factors by affecting the PI3K/Akt signaling pathway mediated by EGFR and TLR4.

  • Unveiling the Anti‐Inflammatory Mechanism of Ziziphus jujuba Mill. var. spinosa Flowers: Network Pharmacology, Molecular Docking and Experimental Validation

    by Yanan Fu, Cuicui Xu, Jiafu Wan, Wenyong Qiao, Qingyu Yan, Xianchen Du, Rongshen Ma, Jiayi Li, Qingmei Guo

    During the cultivation of Ziziphus jujuba Mill. var. spinosa trees, two varieties exhibiting floral sterility were identified. Their flowers are often discarded, resulting in resource wastage. Therefore, non‐targeted metabolomics technology was employed to characterize the chemical composition of Z. jujuba Mill. var. spinosa flowers. Network pharmacology was then utilized to explore their medicinal active components and mechanisms of action, which were validated through molecular docking and in vitro anti‐inflammatory experiments. Results revealed that 3851 metabolites were identified in Z. jujuba Mill. var. spinosa flowers, with 23 potential compounds screened. Among these, 212 targets were directly involved in inflammatory responses. KEGG enrichment analysis suggested that Z. jujuba Mill. var. spinosa flowers may exert anti‐inflammatory effects through the TNF signaling pathway, Toll‐like receptor signaling pathway, Th17 cell differentiation, and hypoxia‐inducible factor‐1 pathway. Molecular docking results indicated that active components in Z. jujuba Mill. var. spinosa flowers exhibit good binding affinity with key inflammatory targets. In vitro anti‐inflammatory assays validated that the ethanol extract of Z. jujuba Mill. var. spinosa flowers reduces the expression of TNF‐α, IL‐1β, and IL‐6, thereby alleviating inflammation. This study preliminarily demonstrates that Z. jujuba Mill. var. spinosa flowers contain anti‐inflammatory active components, and the associated bioactive substances hold potential for development into anti‐inflammatory drugs.

  • Open Access

    Peripheral blood biomarkers and mild behavioral impairment in mild cognitive impairment: Clinical correlations and mechanistic insights

    by Wen-Yong Qiao, Qing-Mei Guo, Xu-Hao Li

    In the context of global aging, mild behavioral impairment (MBI) is present in 48.9% of patients with mild cognitive impairment (MCI). MBI, a neurobehavioral syndrome in the elderly, is an independent risk factor for cognitive decline and is closely related to peripheral blood biomarkers associated with Alzheimer's disease, offering new diagnostic and interventional avenues for early MCI. To summarize evidence on peripheral blood biomarkers related to MBI and their underlying mechanisms involving neuroinflammation, tau pathology, and oxidative stress, a systematic review of studies published between 2015 and 2024 was conducted. MBI is closely associated with peripheral blood biomarker changes. Neuroinflammatory markers like glial fibrillary acidic protein and neurofilament light indicate astrocyte activation and neural circuit disruption, with glial fibrillary acidic protein levels correlating with impulse dyscontrol scores. Chitinase-3-like protein 1, a marker of blood-brain barrier integrity, exacerbates neuroinflammation and is linked to depressive symptoms and hippocampal atrophy. Elevated phosphorylated tau proteins in blood correlate with brain tau deposition, increasing the risk of MBI and impairing cognition. Oxidative stress markers damage neurons and disrupt neurotransmission, and concurrent alterations in malondialdehyde and superoxide dismutase levels significantly elevate the risk of MBI. The correlation between MBI and biomarkers offers new diagnostic and interventional directions for early MCI. Future research should standardize MBI assessment, conduct longitudinal studies, explore biomarker-MBI relationships, investigate psychosocial impacts, and develop advanced detection methods.


  • Open Access

    A review of the sources and pharmacological research of morroniside

    by Pengliang Shi, Bingqing Zheng, Shiyao Zhang, Qingmei Guo

    Introduction: Morroniside (Mor) is a bioactive compound found in Corni Fructus (CF) [Cornaceae; Cornus officinalis Siebold & Zucc.], which has been used as medicine and food in China, Korea, and Japan for over 2,000 years. This review summarizes recent progress on Mor, specifically focusing on its distribution, isolation, detection, and various pharmacological effects.Methods: A literature survey on Mor was conducted using electronic databases such as PubMed, ScienceDirect, CNKI, and Google Scholar. After removing TCM prescription-related standards, medicinal herb processing-related research, and other irrelevant works of literature, we obtained relevant information on Mor’s biological and pharmacological properties.Results: The main conclusions are as follows: Mor is widely distributed in the plant kingdom; the methods for extracting and isolating Mor are well established; and the technology for detecting it is accurate. Mor exhibits numerous pharmacological effects. Along with CF, Mor has shown renoprotective effects against diabetes, hepatoprotective effects against diabetes, triptolide, and nonalcoholic steatohepatitis, and boneprotective effects against osteoporosis and osteoarthritis. In addition, researchers have also explored other pharmacological effects of Mor, including neuroprotective effects against focal cerebral ischemia, spinal cord injury, and Alzheimer’s disease; cardioprotective effects against acute myocardial infarction; protection of the digestive system from gastritis, inflammatory bowel disease, and colitis; protection of the skin by promoting hair growth, wound healing, and flap survival; and protection of the lungs from acute lung injury and pulmonary fibrosis. Moreover, Mor has anti-obesity effects, anti-inflammatory effects in the eye, and improves follicular development.Discussion: Overall, this review provides a comprehensive understanding of the pharmacological effects of Mor, from which the limitations of the current research can be understood, which will help facilitate future research.


  • Open Access

    Discrepancy Study of the Chemical Constituents of Panax Ginseng from Different Growth Environments with UPLC-MS-Based Metabolomics Strategy

    by Yizheng Sun, Xiaoyan Liu, Xiaojie Fu, Wei Xu, Qingmei Guo, Youbo Zhang

    Panax ginseng (P. ginseng), the dried root and rhizome of P. ginseng C. A. Meyer, is widely used in many fields as dietary supplements and medicine. To characterize the chemical constituents in P. ginseng cultivated in different growth environments, a UPLC-TOF-MS method was established for qualitative analysis. Four hundred and eight ginsenosides, including 81 new compounds, were characterized in P. ginseng from different regions. Among the detected compounds, 361 ginsenosides were recognized in P. ginseng cultivated in the region of Monsoon Climate of Medium Latitudes, possessing the largest amount of ginsenosides in all samples. Furthermore, 41 ginsenosides in 12 batches of P. ginsengs were quantified with a UPLC-MRM-MS method, and P. ginsengs from different regions were distinguished via chemometric analysis. This study showed that the different environments have a greater influence on P. ginseng, which laid a foundation for further quality control of the herb.


  • Open Access

    Characterization of Ginsenosides from the Root of Panax ginseng by Integrating Untargeted Metabolites Using UPLC-Triple TOF-MS

    by Yizheng Sun, Xiaojie Fu, Ying Qu, Lihua Chen, Xiaoyan Liu, Zichao He, Jing Xu, Jiao Yang, Wen Ma, Jun Li, et al.

    To compare the chemical distinctions of Panax ginseng Meyer in different growth environments and explore the effects of growth-environment factors on P. ginseng growth, an ultra-performance liquid chromatography–tandem triple quadrupole time-of-flight mass spectrometry (UPLC-Triple-TOF-MS/MS) was used to characterize the ginsenosides obtained by ultrasonic extraction from P. ginseng grown in different growing environments. Sixty-three ginsenosides were used as reference standards for accurate qualitative analysis. Cluster analysis was used to analyze the differences in main components and clarified the influence of growth environment factors on P. ginseng compounds. A total of 312 ginsenosides were identified in four types of P. ginseng, among which 75 were potential new ginsenosides. The number of ginsenosides in L15 was the highest, and the number of ginsenosides in the other three groups was similar, but it was a great difference in specie of ginsenosides. The study confirmed that different growing environments had a great influence on the constituents of P. ginseng, and provided a new breakthrough for the further study of the potential compounds in P. ginseng.